99 related articles for article (PubMed ID: 470340)
1. The effect of a liver protein synthesis inhibitor on plasma SAA levels in a model of accelerated amyloid deposition.
Kisilevsky R; Benson MD; Axelrad MA; Boudreau L
Lab Invest; 1979 Sep; 41(3):206-10. PubMed ID: 470340
[TBL] [Abstract][Full Text] [Related]
2. Effect of colchicine on experimental amyloidosis in two CBA/J mouse models. Chronic inflammatory stimulation and administration of amyloid-enhancing factor during acute inflammation.
Brandwein SR; Sipe JD; Skinner M; Cohen AS
Lab Invest; 1985 Mar; 52(3):319-25. PubMed ID: 3974202
[TBL] [Abstract][Full Text] [Related]
3. Further characterization of amyloid-enhancing factor.
Axelrad MA; Kisilevsky R; Willmer J; Chen SJ; Skinner M
Lab Invest; 1982 Aug; 47(2):139-46. PubMed ID: 7109539
[TBL] [Abstract][Full Text] [Related]
4. Kinetics of amyloid deposition. II. The effects of dimethylsulfoxide and colchicine therapy.
Kisilevsky R; Boudreau L; Foster D
Lab Invest; 1983 Jan; 48(1):60-7. PubMed ID: 6823092
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of the amyloid SAA 3 gene in liver and peritoneal macrophages of mice undergoing dissimilar inflammatory episodes.
Rokita H; Shirahama T; Cohen AS; Meek RL; Benditt EP; Sipe JD
J Immunol; 1987 Dec; 139(11):3849-53. PubMed ID: 3680951
[TBL] [Abstract][Full Text] [Related]
6. Prostaglandin E1 inhibition of experimental amyloidosis in CBA/J mice.
Brandwein SR; Sipe JD; Skinner M; Cohen AS
J Rheumatol; 1985 Jun; 12(3):418-26. PubMed ID: 4045840
[TBL] [Abstract][Full Text] [Related]
7. Kinetics of amyloid deposition. I. The effects of amyloid-enhancing factor and splenectomy.
Kisilevsky R; Boudreau L
Lab Invest; 1983 Jan; 48(1):53-9. PubMed ID: 6823091
[TBL] [Abstract][Full Text] [Related]
8. Colchicine in acute inflammation: stimulation of production of interleukin-1 and modulation of the acute phase serum amyloid A protein response.
Brandwein SR; Sipe JD; Tatsuta E; Skinner M; Cohen AS
J Rheumatol; 1984 Oct; 11(5):597-601. PubMed ID: 6334740
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-1 and the acute-phase response: induction of mouse liver serum amyloid A mRNA by murine recombinant interleukin-1.
Weinstein JA; Taylor JM
J Trauma; 1987 Nov; 27(11):1227-32. PubMed ID: 3119866
[TBL] [Abstract][Full Text] [Related]
10. Dexamethasone modulation of LPS, IL-1, and TNF stimulated serum amyloid A synthesis in mice.
Ghezzi P; Sipe JD
Lymphokine Res; 1988; 7(2):157-66. PubMed ID: 3261378
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitin: its potential significance in murine AA amyloidogenesis.
Chronopoulos S; Lembo P; Alizadeh-Khiavi K; Ali-Khan Z
J Pathol; 1992 Jun; 167(2):249-59. PubMed ID: 1321903
[TBL] [Abstract][Full Text] [Related]
12. Accelerated amyloid deposition in mice treated with the aspartic protease inhibitor, pepstatin.
Yamada T; Liepnieks J; Benson MD; Kluve-Beckerman B
J Immunol; 1996 Jul; 157(2):901-7. PubMed ID: 8752944
[TBL] [Abstract][Full Text] [Related]
13. Temporal relationship between glycosaminoglycan accumulation and amyloid deposition during experimental amyloidosis. A histochemical study.
Snow AD; Kisilevsky R
Lab Invest; 1985 Jul; 53(1):37-44. PubMed ID: 2409350
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and secretion of serum amyloid protein A (SAA) by hepatocytes in mice treated with casein.
Benson MD; Kleiner E
J Immunol; 1980 Feb; 124(2):495-9. PubMed ID: 6985931
[No Abstract] [Full Text] [Related]
15. Acute effects of ethionine stereoisomers on hepatic RNA and protein synthesis in swiss mice.
Berry DE; Friedman MA
Cancer Biochem Biophys; 1976 Aug; 1(5):245-50. PubMed ID: 975026
[TBL] [Abstract][Full Text] [Related]
16. Increased serum amyloid a levels reflect colitis severity and precede amyloid formation in IL-2 knockout mice.
de Villiers WJ; Varilek GW; de Beer FC; Guo JT; Kindy MS
Cytokine; 2000 Sep; 12(9):1337-47. PubMed ID: 10975993
[TBL] [Abstract][Full Text] [Related]
17. Serum amyloid A, in vivo splenic cholesterol export and its potential implications in hemolytic disorders.
Li C; Kisilevsky R
Amyloid; 2008 Dec; 15(4):246-54. PubMed ID: 19065296
[TBL] [Abstract][Full Text] [Related]
18. Characterization of splenic glycosaminoglycans accumulated in vivo in experimentally induced amyloid-susceptible and amyloid-resistant mice.
Sugumaran G; Elliott-Bryant R; Phung N; Vitseva O; Kuberan B; Lech M
Scand J Immunol; 2004 Dec; 60(6):574-83. PubMed ID: 15584968
[TBL] [Abstract][Full Text] [Related]
19. Brefeldin A inhibits experimentally induced AA amyloidosis.
Stenstad T; Husby G
J Rheumatol; 1996 Jan; 23(1):93-100. PubMed ID: 8838515
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical detection of serum amyloid A protein in the liver and the kidney after casein injection.
Miura K; Takahashi Y; Shirasawa H
Lab Invest; 1985 Oct; 53(4):453-63. PubMed ID: 3900582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
